PharmaCielo Ltd.
PCLOF
$0.0478
-$0.0067-12.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.99% | -4.84% | 61.80% | -128.33% | 22.87% |
| Total Depreciation and Amortization | -155.68% | -46.76% | 59.77% | -83.77% | -0.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.70% | 145.91% | -77.37% | 197.92% | 14.77% |
| Change in Net Operating Assets | 97.11% | -123.81% | 33.12% | 278.75% | -60.53% |
| Cash from Operations | 8.37% | -41.79% | 74.60% | -80.32% | 42.29% |
| Capital Expenditure | -- | -- | -- | -875.00% | -120.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -81.79% | 287.73% | 3.85% |
| Cash from Investing | -- | -100.00% | -81.36% | 282.24% | -2.06% |
| Total Debt Issued | -100.00% | 112.70% | -82.64% | 113.53% | -43.33% |
| Total Debt Repaid | 82.33% | -528.66% | 81.98% | -357.45% | 77.04% |
| Issuance of Common Stock | 42.82% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | -- | -- | -- |
| Cash from Financing | 14.52% | -5.19% | -66.42% | 87.44% | -33.93% |
| Foreign Exchange rate Adjustments | 84.85% | -222.22% | -68.60% | 1,533.33% | 83.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.55% | -217.82% | 205.73% | 146.04% | 77.11% |
